tiprankstipranks
Genmab A/S (GB:0MGB)
:0MGB
UK Market

Genmab A/S (0MGB) Financial Statements

Compare
10 Followers

Genmab A/S Financial Overview

Genmab A/S's market cap is currently kr100.84B. The company's EPS TTM is kr122.592; its P/E ratio is 12.95; Genmab A/S is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is kr16.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 16.25B$ 14.51B---
Operating Income$ 5.32B$ 6.27B$ 3.02B$ 6.31B$ 2.80B
EBITDA$ 5.96B$ 8.65B$ 4.24B$ 6.17B$ 3.00B
Net Income$ 4.35B$ 6.81B$ 3.01B$ 4.76B$ 2.17B
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 35.29B$ 30.12B$ 24.63B$ 21.14B$ 15.14B
Total Debt$ 770.00M$ 597.00M$ 425.00M$ 319.00M$ 181.00M
Net Debt$ -27.36B$ -21.73B$ -18.91B$ -15.76B$ -10.79B
Total Liabilities$ 3.68B$ 2.84B$ 2.43B$ 2.02B$ 1.10B
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 7.00B$ 3.60B$ 1.98B$ 6.13B$ 1.22B
Operating Cash Flow$ 7.38B$ 3.91B$ 2.23B$ 6.43B$ 1.33B
Investing Cash Flow
Financing Cash Flow
Currency in USD

Genmab A/S Earnings and Revenue History

Genmab A/S Debt to Assets

Genmab A/S Cash Flow

Genmab A/S Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis